直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

Federal Circuit IP Blog

Federal Circuit Says PTAB’s Delay Is Not a Reviewable “Shenanigan” Under APA

February 2, 2026

Authored and Edited by P. Michael Nielsen; Christopher B. Anderson; Erik R. Puknys

In Ethanol Boosting Systems, LLC v. Ford Motor Company, No. 24-1381 (Fed. Cir. Dec 23, 2025), the Federal Circuit affirmed the PTAB’s holding of obviousness and upheld the Board’s authority to institute the proceeding.

Ford filed IPRs seeking cancelation of three Ethanol Boosting Systems (“EBS”) patents related to optimized fuel management systems. The Board initially denied institution after adopting a construction of key terms from a parallel District Court proceeding. EBS appealed the District Court’s construction and Ford petitioned for re-hearing pending the resolution of EBS’s appeal. After the Federal Circuit vacated the District Court’s claim construction, the Board instituted IPR and invalidated the EBS patents on obviousness grounds. EBS again appealed, arguing that the Board’s delay between Ford’s petition for rehearing and the Board’s grant of the petition—a 15-month delay—was an “ultra vires stay” that exceeded the Board’s statutory authority.

On this subsequent appeal, the Federal Circuit sided with the PTAB on all issues. The Court saw EBS’s challenge to the “stay” as a “challenge to the propriety of the [IPR] institution” noting that overturning IPR institution would require the Court to “uproot the finality of the Board’s reconsideration decision.” The Court explained that institution decisions are only reviewable under 35 U.S.C. § 314(d) if the Board acted “beyond its statutory authority—[which] would constitute a ‘shenanigan’ that may be properly reviewable” under the Administrative Procedure Act ("APA”). The Board’s stay here was not a reviewable “shenanigan” because it was “closely tied to the application and interpretation of statutes related to the Patent Office’s decision to initiate IPR,” which “without more, do not overcome § 314(d)’s bar.” The Court also affirmed the Board’s rulings on the merits.

Tags

Patent Trial and Appeal Board (PTAB)

Related Practices

Appeals, Issues, and Legal Strategy

Federal Circuit and Supreme Court Appeals

Global IP Enforcement, Litigation, and Trials

Patent Litigation and Trials

Patent Office Invalidation Proceedings

PTAB Invalidation Proceedings: IPR and PGR

Related Industries

Energy

Clean Energy and Renewables

Transportation and Logistics

Automotive and Smart Mobility Tech

Related Offices

Palo Alto, CA

Reston, VA

Contacts

P. Michael Nielsen
Associate
Reston, VA
+1 571 203 2723
Email
Christopher B. Anderson
Associate
Reston, VA
+1 571 203 2765
Email
Erik R. Puknys
Partner
Palo Alto, CA
+1 650 849 6644
Email

Copyright © 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. 

DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.

Related Insights

Lecture

IPIC/McGill Summer IP Course 2026: Understanding Trademarks

July 14, 2026

Montreal

Conference

7th International Conference on Biofuels and Bioenergy

June 25-26, 2026

Edinburgh

Charitable

Bridges From School to Work Gala 2026

June 22, 2026

Washington, DC

Lecture

Munich Licensing Summer Course 2026

June 18-19, 2026

Munich

Conference

2026 Copyright Society Annual Meeting

June 14-16, 2026

Louisville

Conference

17th Summit on Biosimilars & Innovator Biologics

June 2-3, 2026

New York

Reception

12th Annual Georgia Asian Pacific American Bar Association Gala

May 21, 2026

Atlanta

Conference

BIA Start-up Festival

May 21, 2026

London

At the PTAB Blog

Before the Holding, the Message: Director Squires Uses Magnolia Medical to Outline PTAB Discretionary Denial Policy Changes

May 20, 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP